RHEACELL
Phase 3Leader for immunomodulatory and tissue-regenerative stem cell therapeutics
Founded
2017
Focus
Cell & Gene Therapy
About
Leader for immunomodulatory and tissue-regenerative stem cell therapeutics
Funding History
2Total raised: $17.5M
Series A$15MBoehringer Ingelheim Venture FundMar 15, 2022
Seed$2.5MHigh-Tech GründerfondsJun 15, 2020
Company Info
TypePrivate
Founded2017
LocationHeidelberg, Germany
StagePhase 3
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile